Cargando…

Alphavirus Restriction by IFITM Proteins

Interferon inducible transmembrane proteins (IFITMs) are broad‐spectrum antiviral factors. In cell culture the entry of many enveloped viruses, including orthomyxo‐, flavi‐, and filoviruses, is inhibited by IFITMs, though the mechanism(s) involved remain unclear and may vary between viruses. We demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Weston, Stuart, Czieso, Stephanie, White, Ian J., Smith, Sarah E., Wash, Rachael S., Diaz‐Soria, Carmen, Kellam, Paul, Marsh, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025721/
https://www.ncbi.nlm.nih.gov/pubmed/27219333
http://dx.doi.org/10.1111/tra.12416
_version_ 1782454003048644608
author Weston, Stuart
Czieso, Stephanie
White, Ian J.
Smith, Sarah E.
Wash, Rachael S.
Diaz‐Soria, Carmen
Kellam, Paul
Marsh, Mark
author_facet Weston, Stuart
Czieso, Stephanie
White, Ian J.
Smith, Sarah E.
Wash, Rachael S.
Diaz‐Soria, Carmen
Kellam, Paul
Marsh, Mark
author_sort Weston, Stuart
collection PubMed
description Interferon inducible transmembrane proteins (IFITMs) are broad‐spectrum antiviral factors. In cell culture the entry of many enveloped viruses, including orthomyxo‐, flavi‐, and filoviruses, is inhibited by IFITMs, though the mechanism(s) involved remain unclear and may vary between viruses. We demonstrate that Sindbis and Semliki Forest virus (SFV), which both use endocytosis and acid‐induced membrane fusion in early endosomes to infect cells, are restricted by the early endosomal IFITM3. The late endosomal IFITM2 is less restrictive and the plasma membrane IFITM1 does not inhibit normal infection by either virus. IFITM3 inhibits release of the SFV capsid into the cytosol, without inhibiting binding, internalization, trafficking to endosomes or low pH‐induced conformational changes in the envelope glycoprotein. Infection by SFV fusion at the cell surface was inhibited by IFITM1, but was equally inhibited by IFITM3. Furthermore, an IFITM3 mutant (Y20A) that is localized to the plasma membrane inhibited infection by cell surface fusion more potently than IFITM1. Together, these results indicate that IFITMs, in particular IFITM3, can restrict alphavirus infection by inhibiting viral fusion with cellular membranes. That IFITM3 can restrict SFV infection by fusion at the cell surface equivalently to IFITM1 suggests that IFITM3 has greater antiviral potency against SFV. [Image: see text]
format Online
Article
Text
id pubmed-5025721
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley & Sons A/S
record_format MEDLINE/PubMed
spelling pubmed-50257212016-10-03 Alphavirus Restriction by IFITM Proteins Weston, Stuart Czieso, Stephanie White, Ian J. Smith, Sarah E. Wash, Rachael S. Diaz‐Soria, Carmen Kellam, Paul Marsh, Mark Traffic Original Articles Interferon inducible transmembrane proteins (IFITMs) are broad‐spectrum antiviral factors. In cell culture the entry of many enveloped viruses, including orthomyxo‐, flavi‐, and filoviruses, is inhibited by IFITMs, though the mechanism(s) involved remain unclear and may vary between viruses. We demonstrate that Sindbis and Semliki Forest virus (SFV), which both use endocytosis and acid‐induced membrane fusion in early endosomes to infect cells, are restricted by the early endosomal IFITM3. The late endosomal IFITM2 is less restrictive and the plasma membrane IFITM1 does not inhibit normal infection by either virus. IFITM3 inhibits release of the SFV capsid into the cytosol, without inhibiting binding, internalization, trafficking to endosomes or low pH‐induced conformational changes in the envelope glycoprotein. Infection by SFV fusion at the cell surface was inhibited by IFITM1, but was equally inhibited by IFITM3. Furthermore, an IFITM3 mutant (Y20A) that is localized to the plasma membrane inhibited infection by cell surface fusion more potently than IFITM1. Together, these results indicate that IFITMs, in particular IFITM3, can restrict alphavirus infection by inhibiting viral fusion with cellular membranes. That IFITM3 can restrict SFV infection by fusion at the cell surface equivalently to IFITM1 suggests that IFITM3 has greater antiviral potency against SFV. [Image: see text] John Wiley & Sons A/S 2016-06-24 2016-09 /pmc/articles/PMC5025721/ /pubmed/27219333 http://dx.doi.org/10.1111/tra.12416 Text en © 2016 The Authors. Traffic published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Weston, Stuart
Czieso, Stephanie
White, Ian J.
Smith, Sarah E.
Wash, Rachael S.
Diaz‐Soria, Carmen
Kellam, Paul
Marsh, Mark
Alphavirus Restriction by IFITM Proteins
title Alphavirus Restriction by IFITM Proteins
title_full Alphavirus Restriction by IFITM Proteins
title_fullStr Alphavirus Restriction by IFITM Proteins
title_full_unstemmed Alphavirus Restriction by IFITM Proteins
title_short Alphavirus Restriction by IFITM Proteins
title_sort alphavirus restriction by ifitm proteins
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025721/
https://www.ncbi.nlm.nih.gov/pubmed/27219333
http://dx.doi.org/10.1111/tra.12416
work_keys_str_mv AT westonstuart alphavirusrestrictionbyifitmproteins
AT cziesostephanie alphavirusrestrictionbyifitmproteins
AT whiteianj alphavirusrestrictionbyifitmproteins
AT smithsarahe alphavirusrestrictionbyifitmproteins
AT washrachaels alphavirusrestrictionbyifitmproteins
AT diazsoriacarmen alphavirusrestrictionbyifitmproteins
AT kellampaul alphavirusrestrictionbyifitmproteins
AT marshmark alphavirusrestrictionbyifitmproteins